Your browser doesn't support javascript.
Unique mutations in SARS-CoV-2 Omicron subvariants' non-spike proteins: Potential impacts on viral pathogenesis and host immune evasion.
Hossain, Anamica; Akter, Shammi; Rashid, Alfi Anjum; Khair, Sabik; Alam, A S M Rubayet Ul.
  • Hossain A; Department of Microbiology, University of Dhaka, Dhaka, 1000, Bangladesh.
  • Akter S; Department of Microbiology, University of Dhaka, Dhaka, 1000, Bangladesh.
  • Rashid AA; Department of Microbiology, University of Dhaka, Dhaka, 1000, Bangladesh.
  • Khair S; Department of Microbiology, University of Dhaka, Dhaka, 1000, Bangladesh.
  • Alam ASMRU; Department of Microbiology, Jashore University of Science and Technology, Jashore, 7408, Bangladesh. Electronic address: rubayetulalam04@gmail.com.
Microb Pathog ; 170: 105699, 2022 Sep.
Article in English | MEDLINE | ID: covidwho-1991210
ABSTRACT
SARS-CoV-2 is the causative agent behind the ongoing COVID-19 pandemic. This virus is a cumulative outcome of mutations, leading to frequent emergence of new variants and their subvariants. Some of them are a matter of high concern, while others are variants of interest for studying the mutational effect. The major five variants of concern (VOCs) are Alpha (B.1.1.7), Beta (B.1.315), Gamma (P.1), Delta (B.1.617.2), and Omicron (B.1.1.529.*/BA.*). Omicron itself has >100 subvariants at present, among which BA.1 (21K), BA.2 (21L), BA.4 (22A), BA.5 (22B), and BA.2.12.1 (22C) are the dominant ones. Undoubtedly, these variants and sometimes their progeny subvariants have significant differences in their spike region that impart them the unique properties they harbor. But alongside, the mutations in their non-spike regions could also be responsible elements behind their characteristics, such as replication time, virulence, survival, host immune evasion, and such. There exists a probability that these mutations of non-spike proteins may also impart epistatic effects that are yet to be brought to light. The focus of this review encompasses the non-spike mutations of Omicron, especially in its widely circulating subvariants (BA.1, BA.2, BA.4, BA.5, and BA.2.12.1). The mutations such as in NSP3, NSP6, NSP13, M protein, ORF7b, and ORF9b are mentioned few of all, which might have led to the varying properties, including growth advantages, higher transmission rate, lower infectivity, and most importantly better host immune evasion through natural killer cell inactivation, autophagosome-lysosome fusion prevention, host protein synthesis disruption, and so on. This aspect of Omicron subvariants has not yet been explored. Further study of alteration of expression or interaction profile of these non-spike mutations bearing proteins, if present, can add a great deal of knowledge to the current understanding of the viral properties and thus effective prevention strategies.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immune Evasion / COVID-19 Type of study: Experimental Studies / Prognostic study Topics: Variants Limits: Humans Language: English Journal: Microb Pathog Journal subject: Communicable Diseases / Microbiology Year: 2022 Document Type: Article Affiliation country: J.micpath.2022.105699

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Immune Evasion / COVID-19 Type of study: Experimental Studies / Prognostic study Topics: Variants Limits: Humans Language: English Journal: Microb Pathog Journal subject: Communicable Diseases / Microbiology Year: 2022 Document Type: Article Affiliation country: J.micpath.2022.105699